Context: In February 2022, nucleic acid delivery companyGenevant Sciencesand clinical-stage biopharmaceutical companyArbutus Biopharma Corporationsued Moderna for allegedly infringing six U.S.
LONDON, Sept 25 (Reuters) - Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the
BioNTech and Pfizer must pay damages to Moderna for the use of one of its patents in Germany. This was the ruling handed down today by Düsseldorf Regional Court in the dispute over mRNA vaccines. It
March 5 - Pfizer (PFE.N) and BioNTech (22UAy.DE) won a round in their legal battle with Moderna (MRNA.O) over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two
total 1 pages, 4 items